Can open-source R&D reinvigorate drug research?
By B. Munos. 2006
123 citations recorded by the source corpus.
The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?
Subfields: Economics and Econometrics, Immunology, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Immunology
In Computational Chemistry & Drug Discovery
Citations in the corpus
- Is open innovation the way forward for big pharma? (2010, methodology): “Following on from pioneering demonstrations of open source development in the software industry — leading to products such as the Linux operating syste”